A UK-wide survey of 2252 adults revealed that women and adults under 55 were most likely to report finding the lockdown challenging. The study highlights the need for targeted interventions to address physical, psychological, and social impacts of the pandemic.
A recent study published in Applied Ergonomics compared standardized processes for community pharmacists with their real-world practices, revealing a significant gap. The researchers identified four main themes: efficiency, resource availability, thoroughness, and delegating safeguards. Further research is needed to adapt procedures to...
Research reveals a significant drop in people seeking help for mental illness and self-harm during the first UK lockdown, with treatment gaps greatest for working-age individuals and those from deprived areas. The study found that anxiety disorders decreased by 47.8% and antidepressant prescriptions dropped by 36.4%.
A national study of general practices in England found that diagnostic error (60%), medication incidents (25%), and delayed referrals (11%) are the main causes of avoidable harm. Researchers identified patient factors such as old age and multiple health problems, highlighting challenges in protecting patients from harm.
A new research study reveals weaknesses in risk-based regulation, making it impossible for regulators to have a unified understanding of the risks posed by discharge from hospital. This leaves patients vulnerable to physical harm and dignity loss.
A new digital intervention developed by pharmacists has significantly reduced hazardous prescribing rates in general practice, with a 43% reduction reported after 12 months. The SMASH intervention uses real-time data to identify patients at risk and provides near-constant feedback to prescribers.
A study analyzing electronic health records found a significant reduction in diagnoses for common physical and mental health conditions during the COVID-19 pandemic. This included a 50% drop in Type 2 diabetes diagnoses, with reductions of up to 44% seen in malignant cancer and circulatory system diseases.
A pilot programme has been launched in Greater Manchester pharmacies to provide personalized support to patients with depression or anxiety. The AMPLIPHY service enables pharmacists to guide patients in setting their own goals and objectives, aiming to improve treatment outcomes and patient safety.